For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Celestica Inc. (CLS) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-10-08): Designation Low · Gem Score -30 (−100…+100 Quality+Value blend) · Quality 39 · Value -76 · Sentiment 39 (timing only, not weighted) · Composite fair value $219.71 vs $329.94 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Celestica Inc.
CLS NYSECelestica Inc. is a global provider of supply chain solutions and electronic manufacturing services for equipment manufacturers and service providers. The company supports customers across advanced technology and cloud-connected markets through two main business segments: Advanced Technology Solutions and Connectivity & Cloud Solutions. Its services include product design and development, engineering, component sourcing, electronics assembly, testing, systems integration, logistics, asset management, and after-market repair and return support. Celestica serves industries such as aerospace and defense, industrial, health tech, capital equipment, communications, enterprise computing, servers, and storage. Based in Toronto, Canada, Celestica plays an important role in helping customers manage complex product lifecycles and deliver specialized technology hardware across global markets.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 7.16
Total Equity: $2.22B
Shares: 116,200,000
Total Debt: $0.00
Cash: $595.60M
EBITDA: $1.22B
Total Debt: $0.00
Cash: $595.60M
Revenue: $12.39B
Revenue: $12.39B
Revenue: $12.39B
Total Equity: $2.22B
Tax Rate: 15.3%
Equity: $2.22B
Total Debt: $0.00
Cash: $595.60M
Current Liabilities: $3.94B
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $2.22B
Shares: 116,200,000
Shares: 116,200,000
CapEx: -$201.20M
Shares: 116,200,000
Stock Price: $296.55
Net Income: $832.50M
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 22, 2026 4:28pm (46d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $7.3B | $8.0B | $9.6B | $12.4B |
| Cost of Revenue | $6.6B | $7.2B | $8.6B | $10.9B |
| Gross Profit | $649.7M | $754.1M | $1.0B | $1.5B |
| Operating Expenses | $360.4M | $415.8M | $434.4M | $453.4M |
| Operating Income | $289.3M | $338.3M | $599.3M | $1.0B |
| Net Income | $180.1M | $244.4M | $428.0M | $832.5M |
| EBITDA | $405.2M | $469.1M | $751.2M | $1.2B |
| EPS | $1.46 | $2.03 | $3.62 | $7.22 |
| EPS (Diluted) | $1.46 | $2.03 | $3.61 | $7.16 |
Balance Sheet (Annual)
Last updated: Aug 22, 2026 4:11pm (46d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | — | — | $370.4M | $423.3M | $595.6M |
| Total Current Assets | — | — | $4.5B | $4.5B | $5.7B |
| Total Assets | — | — | $5.9B | $6.0B | $7.2B |
| Current Liabilities | — | — | $3.2B | $3.0B | $3.9B |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | — | — | $4.1B | $4.1B | $5.0B |
| Total Equity | $1.5B | $1.7B | $1.8B | $1.9B | $2.2B |
| Retained Earnings | — | — | -$851.8M | -$423.8M | $408.7M |
Cash Flow (Annual)
Last updated: Aug 22, 2026 4:28pm (46d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | — | $211.1M | $326.2M | $473.9M | $659.5M |
| Capital Expenditure | — | -$109.0M | -$125.1M | -$170.9M | -$201.2M |
| Free Cash Flow | — | $102.1M | $201.1M | $303.0M | $458.3M |
| Acquisitions (net) | — | $0 | $0 | -$36.1M | $0 |
| Net Debt Issued / (Repaid) | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | — | -$34.6M | -$35.6M | -$152.0M | -$153.4M |
| Net Change in Cash | -$69.8M | -$19.5M | -$4.1M | — | — |
Growth Trends (YoY %)
Last updated: Aug 22, 2026 4:28pm (46d ago)| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue Growth | +9.8% | +21.2% | +28.5% |
| Gross Profit Growth | +16.1% | +37.1% | +44.5% |
| Operating Income Growth | +16.9% | +77.2% | +73.7% |
| Net Income Growth | +35.7% | +75.1% | +94.5% |
| EBITDA Growth | +15.8% | +60.1% | +61.9% |
Deep Analysis
Risk : Reward — upside vs downside from this company's own quarters
Computed 2026-10-03 02:02A +1σ run of quarters pays -15%; a −1σ run costs 59%. Ratio -0.3:1 (μ 43.9%, σ 17.8% , 6 pairs).
Older method (repeat-worst-quarter): 1.1 : 1
| Case | Growth | Margin | Fair value | vs price ($329.94) |
|---|---|---|---|---|
| Bull — recovery | +70% | 9.2% | $517.49 | +57% |
| Base — stabilizes | +46% | 8.0% | $261.07 | -21% |
| Bear — keeps slipping | +23% | 6.8% | $122.11 | -63% |
| Stress — last quarter repeats | +28% | 7.9% | $157.86 | -52% |
| Upside — a +1σ run of quarters (v2) | +50% | 7.9% | $281.49 | -15% |
| Stress — a −1σ run of quarters (v2) | +26% | 7.0% | $136.17 | -59% |
Narrative Economics
market-narrative step).
Growth Outlook
Analyzed 2026-09-17 17:23The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
The raw trajectory is genuinely spectacular and hard to argue with on execution: quarterly revenue has gone $2.50B → $2.65B → $2.89B → $3.19B → $3.65B → $4.05B → $4.70B across seven quarters, an 88% cumulative lift, with net margin expanding from 3.6% to 7.8%. TTM revenue is roughly $15.6B against FY2024 $9.65B — that is a 60%+ YoY step-up, not the 47% the momentum module cites, and TTM NI near $1.12B versus $832M for FY2025 already. ROIC at 42% and ROE at 53% on a capital-light EMS base are not typical Celestica numbers — this business ran mid-single-digit ROICs for a decade. So the classification as "high-growth profitable" is defensible on the tape, but the pre-flight framing — cyclical EMS wearing a growth costume — is the more honest read.
The synthesis DCF at $229 versus $330 price is the crux, and I largely agree with its direction while questioning its precision. EV/revenue at 2.46x and EV/EBITDA at 24.8x for a contract manufacturer are historically unprecedented — traditional EMS peers (Jabil, Flex, Sanmina) trade at 0.5–1.0x sales and 8–12x EBITDA. Even generously granting that CCS/HPS mix has structurally shifted Celestica toward hyperscaler ODM work with 8%+ margins, the multiple still embeds the assumption that this margin holds and revenue compounds double-digit through 2028. Bear-side history is unambiguous: EMS margin peaks have always mean-reverted because customer concentration (Celestica's top customers are hyperscalers, deeply concentrated) grants pricing power to the buyer once the capacity crunch eases. The thesis-evaluation score of -12 with bear mass 91.6 vs bull 79.9 feels roughly right.
The contrarian pushback the models under-weight: this cycle may genuinely be different in duration, not kind. Hyperscaler capex guides for 2026 are still ramping (Meta, MSFT, GOOG, AMZN all raised), and Celestica's design-win pipeline in 800G networking and custom ASIC assembly is booked 4-6 quarters forward. If TTM run-rate holds — $4.7B × 4 = $18.8B annualized — and margins even compress to 6.5%, that's $1.22B NI, putting forward P/E near 34x, still expensive but not absurd for a name growing 40%. The Q1 2026 margin dip to 5.2% is the tell worth watching: it may be a one-quarter mix issue, or it may be the first crack. Insider activity — six sales on 2026-08-13 totaling ~23,500 shares with zero buys and only trivial option-exercise activity otherwise — reinforces the "management thinks this is peak" read, though the share counts are small enough to be routine 10b5-1 rather than conviction dumps. I wouldn't over-index on it, but combined with the 87-sales-zero-buys pattern the thesis engine flagged, it's consistent with insiders monetizing a re-rating.
I partially agree with the synthesis overvalued call but think $229 fair value is too punitive — it appears to anchor on pre-AI-cycle EMS multiples that don't account for the mix shift into HPS being real, even if cyclically amplified. My fair value lands closer to $240–275: applying 15-17x forward EBITDA (a reasonable premium to legacy EMS but discount to current 24.8x) on normalized $1.7-1.9B EBITDA gives ~$28-32B EV versus current ~$41.6B. The stock is priced for perpetual AI capex compounding; even a mild 2027 digestion phase (which is the modal EMS outcome, not a tail risk) would drop the multiple 30-40% quickly. Not a short — momentum, earnings revisions, and the fundamental trajectory are all still working — but decisively not a place to initiate. Existing holders should trim; new money should wait for either a $250 entry on a capex-scare selloff or two more quarters of margin durability at 7%+ to validate the structural thesis.
GPT Reading
What jumps out is not that Celestica is merely “better than a typical EMS company,” but how violently the earnings power has inflected in just two years. On a trailing basis through 2026-06-30, revenue is about $15.6B versus $9.65B for calendar 2024 and $7.96B for 2023, while net margin has climbed to 7.2% and operating margin to 8.8%—levels that are exceptional for a company the market historically would have treated as a contract manufacturer. The quarterly progression is even more striking: revenue has gone from $2.50B in 2024-09 to $4.70B in 2026-06, and the latest quarter’s $368.8M of net income is more than 4x the $89.5M posted seven quarters earlier. This is not a case of flat revenue with financial engineering; it is real top-line acceleration paired with margin expansion. Return metrics support that the improvement is substantive: 52.7% ROE and 42.4% ROIC are far too high to dismiss as just “commodity assembly” economics, even allowing for a lean equity base.
The core debate is whether those margins are structural or peak-cycle. My read is that the market is directionally right to award a premium, but has overshot badly at $329.94. Even if I use the stronger trailing window rather than the older annual data, the stock trades around 34x earnings, 2.45x sales, and 24.8x EV/EBITDA for a business with 12.0% gross margins and 7.2% net margins. Those are software-ish multiples being placed on a manufacturing model that still has manufacturing risk, customer concentration risk, and likely capex-cycle exposure. Yes, the business mix has improved, but the recent quarter’s 7.8% margin came alongside a huge revenue surge to $4.70B; that is exactly the kind of combination that investors tend to annualize too aggressively. If Celestica can sustain roughly $1.1B of TTM net income, the valuation is expensive but not insane. If margins slip back even modestly toward 5%-6% on slower growth, today’s multiple compresses fast.
What keeps me from a full-throated bear call is the balance between growth and balance-sheet discipline. Net debt is only about $181M against a $41.6B market cap, the current ratio is 1.23, and 2025 free cash flow was $458.3M after $201.2M of capex. That cash generation lagged net income, so this is not a pristine cash-conversion story, but it is solid enough that the business is not being propped up by leverage. More importantly, the scale-up is broad enough across the reported periods that it does not look like a one-quarter accounting fluke. Annual revenue rose from $7.25B in 2022 to $12.39B in 2025, while annual net income went from $180.1M to $832.5M. When a company quintuples earnings in three years, the prior multiple framework often becomes too conservative. I think that is exactly why simple “this is an EMS stock, therefore low teens P/E” logic is inadequate here.
The strongest case against my cautious stance is straightforward: the market may be seeing a genuine business-model migration before the financial statements fully explain it. If Celestica has moved into more complex, stickier, higher-value programs, then the right comparable set is not old-school low-margin EMS peers, and today’s 34x trailing P/E could compress naturally through earnings growth rather than price decline. The quarterly revenue run-rate now points to something closer to an $18B business than a $12B one, and the latest quarter’s annualized earnings power is near $1.5B. Put a 30x multiple on a credible path to $1.3B-$1.5B of annual earnings and the stock is not obviously absurd. Bulls will also note that insider sales without dollar values or ownership context are weak evidence by themselves, especially after a major rerating.
What would change my mind is either confirmation that this is truly a structurally higher-margin franchise or evidence that the feared digestion has begun. I’d turn more positive if the next two quarters hold revenue above roughly $4.2B and net margin above 7%, because that would show the latest quarter was not just a capex spike. I’d also want to see free cash flow catch up meaningfully with earnings on the next annual print. On the other hand, if quarterly revenue falls back toward the mid-$3B range or net margin retreats to 5%-6%, then the stock is far too expensive and likely deserves a much sharper derating. At $329.94, investors are paying as though the transformation is proven; the numbers show it is real, but not yet proven enough for this price.
Grok Reading
Celestica’s trailing twelve months through mid-2026 put roughly $15.6B of revenue on the board ($4.70B + $4.05B + $3.65B + $3.19B), up nearly 50% from the prior-year window near $10.6B, with TTM net income about $1.12B versus roughly $538M a year earlier. That is not cosmetic: annual revenue scaled from $7.25B in 2022 to $12.39B in 2025 while net income went from $180M to $833M, and the latest quarter alone printed $4.70B revenue and a 7.8% net margin. Operating margin TTM sits near 8.8% and ROIC/ROE at 42%/53%—extraordinary for an electronics manufacturing services name that historically lived on mid-single-digit operating margins and low-teens returns. Free cash flow of $458M against modest net debt (total debt $777M, cash $596M, D/E 0.33) confirms the earnings are converting. The story the raw numbers tell is a real mix and scale inflection, almost certainly AI/server and complex hardware related, not a one-quarter fluke.
At $329.94 and a $41.6B market cap the market is capitalizing that run at 34× TTM earnings, 2.45× sales, and ~25× EV/EBITDA, with a 15× book multiple on only $2.22B of equity. Those are software-ish multiples on a contract manufacturer whose gross margin is still only ~12%. Sequential revenue is still climbing hard, but the secondary signal already flags the quarterly trend as decelerating, and 40% revenue CAGR / 114% earnings CAGR cannot be the steady-state forever. The valuation synthesis fair value near $229–$229 implies the stock is embedding multi-year persistence of mid-20s-plus growth and mid-to-high single-digit margins that EMS history rarely sustains once the capex wave digests. Insider activity—clusters of sales in August 2026 with no meaningful open-market buying—aligns with management treating elevated prices as an exit, not a signal of underappreciation.
The strongest counter is straightforward: the operating leverage and returns look structural enough that “peak cycle” may be the wrong frame. Gross profit nearly doubled from 2023 to 2025 while the balance sheet stayed clean and FCF quality is adequate; if aerospace-defense and high-complexity enterprise work have permanently lifted the mix, a mid-20s earnings multiple on a still-growing $1.1B+ NI base is defensible and $330 is closer to fair than a 30% haircut. Bulls can also note that every recent quarter has beaten the prior on revenue dollars, so the deceleration label may be premature noise inside a still-accelerating absolute run-rate. I weigh that less because even structural mix improvement does not erase customer concentration and OEM capex cyclicality, and 34× / 25× EV/EBITDA already pays for several years of that improvement sticking; the premium over a ~$230 DCF anchor is pure narrative duration risk, not ignored cash flows.
What flips me is concrete: two more quarters that hold revenue above ~$4.5B with net margins stable at or above 7.5% without a sharp drop in bookings commentary would force a higher terminal growth assumption and pull fair value toward the current price; conversely, a sub-$4B revenue quarter or net margin compression back under 5% while AI server spend rhetoric cools would confirm the digestion thesis and open a path well below $250.
Qwen Reading local experiment · off-panel
The most glaring contradiction in this dataset is the disconnect between the "high growth" label and the actual quarterly trajectory. While the momentum metrics scream a 40% revenue CAGR and 113.7% earnings CAGR, the last two quarters tell a story of violent deceleration and margin compression. Revenue grew from $4.05B in Q1 2026 to $4.70B in Q2 2026, a 16% sequential jump, but net income collapsed from $212.3M to $368.8M? No, wait—looking closer, Q1 2026 NI was $212.3M and Q2 2026 NI was $368.8M. That is an increase. However, the margin *dropped* from 5.2% to 7.8%? No, 368.8/4700 is 7.8%. 212.3/4050 is 5.2%. So margins actually *expanded* sequentially. But look at the prior year: Q2 2025 had a 7.3% margin on $2.89B revenue. The current 7.8% margin is only marginally better, yet the stock is trading at a 34x P/E. The real red flag is the "recent_revenue_yoy" of 47.3%. If we compare Q2 2026 ($4.70B) to Q2 2025 ($2.89B), that is indeed ~62% growth. But the "decelerating" trend flag in the secondary signals is correct if we look at the *rate* of change. The jump from $2.65B (Q1 2025) to $2.89B (Q2 2025) was 9%. The jump from $4.05B (Q1 2026) to $4.70B (Q2 2026) is 16%. The growth is accelerating sequentially, but the *base* is getting larger. The critical issue is the valuation multiple relative to the *quality* of the earnings. A 34x P/E for a contract electronics manufacturer (EMS) is historically extreme. EMS companies like Jabil or Flex typically trade at 10-15x earnings. Celestica is trading at 2-3x its peers. This premium is entirely justified only if the "AI infrastructure" narrative is treated as a structural, non-cyclical shift. The data shows net margin expanding from 3.3% in Q1 2025 to 7.8% in Q2 2026. That is a massive improvement, but it is driven by mix shift toward high-complexity AI servers. The risk is that this is a cyclical peak in AI capex, not a permanent structural change. The 46x P/E cited in the pre-flight (likely using a different TTM window or including one-time items) vs the 34x TTM P/E in the canonical metrics suggests the market is pricing in perfection.
The strongest case against my bearish lean is the sheer velocity of the earnings growth. Earnings CAGR of 113.7% is not a typo; it is a reflection of the explosive demand for AI hardware. If Celestica can maintain even 20% growth for the next two years, the current 34x P/E compresses to a reasonable 15-20x. The balance sheet is clean: $776.5M debt vs $595.6M cash, but with $2.22B equity and a current ratio of 1.22, they are not over-leveraged. The operating cash flow of $659.5M against net income of $832.5M is a bit low (80% conversion), but free cash flow of $458.3M is solid. The insider selling is a concern—87 sales, zero buys—but in a stock that has likely tripled, insiders selling is a rational tax event, not necessarily a signal of impending doom. The "platform-monopoly" narrative is weak; Celestica is a contract manufacturer, not a platform. They have no pricing power over their customers (Nvidia, AMD, hyperscalers). They are a supplier. Suppliers do not get 34x P/E unless they are the *only* supplier. Celestica is one of several. This is the core flaw in the bull case: the market is treating a cyclical supplier as a structural winner.
What would change my mind? A quarterly report showing revenue growth above 30% YoY *and* net margin expansion above 8%. If they can sustain 8%+ margins while growing 30%+, the 34x P/E is justified. If growth slows to 15% and margins stay flat, the stock is overvalued. The key metric is the "AI infrastructure" revenue mix. If that segment grows 50%+ and drives the overall growth, the thesis holds. If it is just general electronics, the thesis fails. The current price of $329.94 implies a market cap of $41.6B. For a company with $12.4B revenue and $832M net income, that is a 3.4x P/S and 34x P/E. I am uncommitted to a buy, but I am firmly in the "overvalued" camp for new money. The risk/reward is poor. The stock has already priced in the "AI boom" scenario. Any miss in guidance or a slowdown in AI capex will trigger a multiple compression that could erase 30-40% of the value.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
The trajectory is striking: revenue grew from $7.25B to $15.59B across the window while gross margin expanded from 9.0% to 12.0% and operating margin from 4.0% to 8.8%. Net income more than sextupled from $180M to $1.12B and FCF climbed to $518.7M TTM, all while diluted share count fell from 123.6M to 115.9M (-2.1% CAGR) with SBC at just 0.4% of revenue and buybacks running 149% of SBC. That is unusual operating leverage and unusual capital discipline for an electronics manufacturing services business, historically a commoditized, thin-margin industry.
Verify before trusting this (5)
- Customer concentration in the 10-K — how much of revenue and margin uplift is tied to a handful of hyperscaler/AI infrastructure customers
- Segment mix: CCS (Connectivity and Cloud Solutions) vs ATS growth and margin contribution
- Working capital dynamics — inventory and receivables buildup explaining NI-to-FCF gap
- Debt maturity schedule and covenants given -$274.7M net cash position
- Whether insider sales are 10b5-1 scheduled or discretionary
The composite fair value of $219.71 and signal-adjusted $229.05 sit roughly 30% below the $329.94 price, and the two more conservative methods (DCF $111.29, EPV $43.58) imply the market is paying multiples of the cash-flow-based worth of the business as it stands. Only the anchored-PE method ($440.41) supports today's price, and it does so by extrapolating current peak-cycle earnings power onto a historically thin-margin EMS multiple - exactly the assumption that has burned this sector before. Quality is genuinely better (op margins 4% to ~8.8%, buybacks, clean earnings), which lifts deserved value above the DCF/EPV floors, but not to $330. A reasonable quality-adjusted deserved range is roughly $210-260. The gap is not a screaming short - the business is compounding and the AI/hyperscaler tailwind is real - but the price already bakes in continued mix shift, sustained double-digit growth, and no cyclical give-back. Earnings quality is high, so no haircut; the issue is purely that expectations embedded in the price are demanding.
Verify before trusting this (4)
- Hyperscaler customer concentration and revenue mix in latest 10-Q/AIF
- Guided operating margin trajectory and whether CCS segment margins are structural or cycle-linked
- Backlog/book-to-bill trends and any commentary on 2026 AI capex from top customers
- Share count trajectory and remaining buyback authorization
CLS is riding the strongest active narrative in the market right now: AI server and interconnect buildout. Broadcom's 2.5x AI interconnect disclosure directly lifted the name, and momentum is decisively strong (40% CAGR, recent 47% run) with heavy retail search interest per Zacks. That is a real tailwind pressing the stock regardless of DCF fair value. The CFO transition news is being framed constructively (elevation of the finance chief to a growth-facing role), and an October 27 Investor Day sits as a near catalyst that is already pulling buyers forward.
Verify before trusting this (4)
- October 27 Investor Day tone and any FY guide raise
- Any hyperscaler or Broadcom capex commentary shift
- Whether VIX pushes above 20 and drags high-beta AI names into a rotation
- Sell-side target revisions post-CFO transition
The world is re-plumbing datacenters for accelerated compute, and the scarce link is not the chip but the system around it — high-radix switches, optical interconnect, liquid-cooled racks and the qualified capacity to build them at volume. Hyperscalers have responded by concentrating that work with a short list of trusted partners with design capability, which is exactly the slot CLS occupies. That is why a company inside a mature, low-margin category is printing semiconductor-like growth. The durable part is the structural rise in outsourced system integration and content per rack; the fragile part is that the buyer set is tiny and its capex cadence is lumpy. Expect the demand to stay large through the next 18 months on committed programs, then normalize as capacity catches up and price-downs resume — growth continues, but the rate reverts toward the low-to-mid twenties rather than the fifties.
When we made this prediction on Sep 19, 2026, CLS was $332.49. We expect it to be $295.00 by Mar 2027, and we consider it great value under $230.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Sep 19, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.